SK125495A3 - 1,5-benzodiazepine derivatives, manufacturing process, their use and pharmaceutical compositions containing them - Google Patents
1,5-benzodiazepine derivatives, manufacturing process, their use and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- SK125495A3 SK125495A3 SK1254-95A SK125495A SK125495A3 SK 125495 A3 SK125495 A3 SK 125495A3 SK 125495 A SK125495 A SK 125495A SK 125495 A3 SK125495 A3 SK 125495A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- compound
- phenyl
- compounds
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939307833A GB9307833D0 (en) | 1993-04-15 | 1993-04-15 | Modulators of cholecystokinin and gastrin |
| GB9406037A GB9406037D0 (en) | 1994-03-29 | 1994-03-29 | 1,5 Benzodiazepine derivatives |
| PCT/EP1994/001130 WO1994024151A1 (en) | 1993-04-15 | 1994-04-13 | 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK125495A3 true SK125495A3 (en) | 1996-06-05 |
Family
ID=26302765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1254-95A SK125495A3 (en) | 1993-04-15 | 1994-04-13 | 1,5-benzodiazepine derivatives, manufacturing process, their use and pharmaceutical compositions containing them |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0694040A1 (cs) |
| JP (1) | JPH08508743A (cs) |
| CN (1) | CN1120845A (cs) |
| AU (1) | AU688316B2 (cs) |
| CA (1) | CA2158972A1 (cs) |
| CZ (1) | CZ267695A3 (cs) |
| FI (1) | FI954852A0 (cs) |
| HU (1) | HUT74091A (cs) |
| NO (1) | NO954091L (cs) |
| NZ (1) | NZ265271A (cs) |
| OA (1) | OA10236A (cs) |
| PL (1) | PL311083A1 (cs) |
| SK (1) | SK125495A3 (cs) |
| WO (1) | WO1994024151A1 (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3621416B2 (ja) * | 1993-12-28 | 2005-02-16 | 塩野義製薬株式会社 | 新規なベンゾジアゼピン誘導体 |
| ATE248823T1 (de) * | 1996-12-10 | 2003-09-15 | Zeria Pharm Co Ltd | 1,5-benzodiazepinderivate |
| US6444849B1 (en) | 1997-06-25 | 2002-09-03 | Mitsubishi Chemical Corporation | Amide derivatives |
| JP2000026434A (ja) | 1998-06-05 | 2000-01-25 | Zeria Pharmaceut Co Ltd | 新規１，５−ベンゾジアゼピン誘導体 |
| WO2000037434A1 (fr) * | 1998-12-22 | 2000-06-29 | Mitsubishi Chemical Corporation | Derives d'amide |
| GB201414116D0 (en) | 2014-08-08 | 2014-09-24 | Trio Medicines Ltd | Benzodiazepine derivatives |
| GB201513979D0 (en) | 2015-08-07 | 2015-09-23 | Trio Medicines Ltd | Synthesis of benzodiazepine derivatives |
| BR112022006546A2 (pt) | 2019-10-07 | 2022-08-30 | Kallyope Inc | Agonistas de gpr119 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2641280B1 (fr) * | 1988-12-29 | 1994-01-21 | Roussel Uclaf | Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments |
| FR2659653B1 (fr) * | 1990-03-13 | 1992-05-22 | Rhone Poulenc Sante | Derives de l'uree, leur preparation et les medicaments les contenant. |
| US5206234A (en) * | 1990-10-22 | 1993-04-27 | Merck & Co., Inc. | Benzolactam analogs as antagonists of cck |
| GB9201180D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
-
1994
- 1994-04-13 PL PL94311083A patent/PL311083A1/xx unknown
- 1994-04-13 NZ NZ265271A patent/NZ265271A/en unknown
- 1994-04-13 SK SK1254-95A patent/SK125495A3/sk unknown
- 1994-04-13 CA CA002158972A patent/CA2158972A1/en not_active Abandoned
- 1994-04-13 EP EP94913579A patent/EP0694040A1/en not_active Withdrawn
- 1994-04-13 AU AU65675/94A patent/AU688316B2/en not_active Ceased
- 1994-04-13 HU HU9502977A patent/HUT74091A/hu unknown
- 1994-04-13 WO PCT/EP1994/001130 patent/WO1994024151A1/en not_active Application Discontinuation
- 1994-04-13 CZ CZ952676A patent/CZ267695A3/cs unknown
- 1994-04-13 JP JP6522733A patent/JPH08508743A/ja active Pending
- 1994-04-13 CN CN94191771A patent/CN1120845A/zh active Pending
-
1995
- 1995-10-12 FI FI954852A patent/FI954852A0/fi unknown
- 1995-10-13 NO NO954091A patent/NO954091L/no unknown
- 1995-10-21 OA OA60721A patent/OA10236A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2158972A1 (en) | 1994-10-27 |
| WO1994024151A1 (en) | 1994-10-27 |
| AU688316B2 (en) | 1998-03-12 |
| CZ267695A3 (en) | 1996-04-17 |
| HUT74091A (en) | 1996-11-28 |
| NO954091D0 (no) | 1995-10-13 |
| HU9502977D0 (en) | 1995-12-28 |
| EP0694040A1 (en) | 1996-01-31 |
| CN1120845A (zh) | 1996-04-17 |
| AU6567594A (en) | 1994-11-08 |
| OA10236A (en) | 1997-10-07 |
| PL311083A1 (en) | 1996-02-05 |
| NO954091L (no) | 1995-12-13 |
| FI954852A (fi) | 1995-10-12 |
| NZ265271A (en) | 1997-06-24 |
| FI954852A0 (fi) | 1995-10-12 |
| JPH08508743A (ja) | 1996-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5585376A (en) | 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity | |
| AU640113B2 (en) | Benzodiazepine analogs | |
| US4820834A (en) | Benzodiazepine analogs | |
| US5618812A (en) | Benzodiazepine derivatives | |
| EP1326849B1 (en) | Benzodiazepine derivatives as inhibitors of gamma secretase | |
| AU679085B2 (en) | Benzodiazepine analogs | |
| US5569654A (en) | Benzodiazepinones | |
| WO1995028399A1 (en) | A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds | |
| US5302591A (en) | Benzodiazepine derivatives | |
| DE69510545T2 (de) | Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine | |
| PL175609B1 (pl) | Pochodne 1,5-benzodiazepiny, kompozycja farmaceutyczna zawierająca pochodne 1,5-benzodiazepiny oraz sposób wytwarzania pochodnych 1,5-benzodiazepiny | |
| SK125495A3 (en) | 1,5-benzodiazepine derivatives, manufacturing process, their use and pharmaceutical compositions containing them | |
| JPH0680650A (ja) | コレシストキニン拮抗薬 | |
| GB2266528A (en) | Benzodiazepine derivatives | |
| HRP940330A2 (en) | Amine derivatives |